APA
Ward R. A., Anderton M. J., Ashton S., Bethel P. A., Box M., Butterworth S., Colclough N., Chorley C. G., Chuaqui C., Cross D. A. E., Dakin L. A., Debreczeni J. É., Eberlein C., Finlay M. R. V., Hill G. B., Grist M., Klinowska T. C. M., Lane C., Martin S., Orme J. P., Smith P., Wang F. & Waring M. J. (20131111). Structure- and reactivity-based development of covalent inhibitors of the activating and gatekeeper mutant forms of the epidermal growth factor receptor (EGFR). : Journal of medicinal chemistry.
Chicago
Ward Richard A, Anderton Mark J, Ashton Susan, Bethel Paul A, Box Matthew, Butterworth Sam, Colclough Nicola, Chorley Christopher G, Chuaqui Claudio, Cross Darren A E, Dakin Les A, Debreczeni Judit É, Eberlein Cath, Finlay M Raymond V, Hill George B, Grist Matthew, Klinowska Teresa C M, Lane Clare, Martin Scott, Orme Jonathon P, Smith Peter, Wang Fengjiang and Waring Michael J. 20131111. Structure- and reactivity-based development of covalent inhibitors of the activating and gatekeeper mutant forms of the epidermal growth factor receptor (EGFR). : Journal of medicinal chemistry.
Harvard
Ward R. A., Anderton M. J., Ashton S., Bethel P. A., Box M., Butterworth S., Colclough N., Chorley C. G., Chuaqui C., Cross D. A. E., Dakin L. A., Debreczeni J. É., Eberlein C., Finlay M. R. V., Hill G. B., Grist M., Klinowska T. C. M., Lane C., Martin S., Orme J. P., Smith P., Wang F. and Waring M. J. (20131111). Structure- and reactivity-based development of covalent inhibitors of the activating and gatekeeper mutant forms of the epidermal growth factor receptor (EGFR). : Journal of medicinal chemistry.
MLA
Ward Richard A, Anderton Mark J, Ashton Susan, Bethel Paul A, Box Matthew, Butterworth Sam, Colclough Nicola, Chorley Christopher G, Chuaqui Claudio, Cross Darren A E, Dakin Les A, Debreczeni Judit É, Eberlein Cath, Finlay M Raymond V, Hill George B, Grist Matthew, Klinowska Teresa C M, Lane Clare, Martin Scott, Orme Jonathon P, Smith Peter, Wang Fengjiang and Waring Michael J. Structure- and reactivity-based development of covalent inhibitors of the activating and gatekeeper mutant forms of the epidermal growth factor receptor (EGFR). : Journal of medicinal chemistry. 20131111.